News | Computed Tomography (CT) | March 29, 2022

CCT Offers a Safer Alternative to Cardiac Catheterization in CAD Diagnosis

The DISCHARGE randomized trial compared the effectiveness of CCT versus ICA as the initial diagnostic imaging strategy for evaluating stable patients with chest pain.

CT scanner

March 29, 2022 – Cardiac computed tomography (CCT) is an accurate, noninvasive diagnostic test for obstructive coronary artery disease (CAD) according to an analysis recently published in The New England Journal of Medicine (NEJM), and poses less risk than the current standard diagnostic test for intermediate-risk patients of invasive coronary angiography (ICA), or cardiac catheterization. CT patients experienced significantly less major procedure-related complications over 3.5 years of follow-up.

The DISCHARGE randomized trial – made up of a 31-institution consortium and led by Prof. Dr. Marc Dewey, head of the Department of Radiology on Campus Charité Mitte – compared the effectiveness of CCT versus ICA as the initial diagnostic imaging strategy for evaluating stable patients with chest pain.

Eric Williamson, MD, MSCCT, president of the Society of Cardiovascular Computed Tomography (SCCT) states: “This study reaffirms that coronary CT angiography should be the first-line test for patients presenting with chest pain. It is safe, effective and quick. A CT first strategy allows physicians to provide relevant findings without the need for an invasive procedure. This is especially important for people who do not have obstructive CAD.”

The more than 3,500 patients enrolled in the trial were randomly assigned CT or ICA as a diagnostic imaging technique after reporting chest pain. Clinical outcomes were similar for both test groups in the study, with 2.1% of patients assigned to CCT and 3% in the ICA group experiencing primary outcomes in major adverse cardiovascular events (MACE).

The primary outcome was a composite of cardiovascular death, non-fatal myocardial infarction and nonfatal stroke over 3.5 years. Key secondary outcomes were major procedure-related complications and self-reported angina. Although MACE risks were similar in both groups, the frequency for major procedure-related complications was lower for patients in the CT group (.5%) than for patients who underwent ICA (1.9%).

CAD is associated with a reduced blood flow in the coronary arteries that supply the heart with oxygen, which can lead to symptoms of chest pain and shortness of breath. Because nearly 60% of patients who are referred for ICA do not have obstructive CAD, this trial proves CT is a viable low-risk alternative to the invasive procedure. 

For more information: https://www.nejm.org/

 


Related Content

News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
News | Computed Tomography (CT)

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
News | Computed Tomography (CT)

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Home September 19, 2023
Home
Subscribe Now